U.S. Hematology Brand Lead, Navtemadlin

U.S. Hematology Brand Lead, Navtemadlin

Societe:
Ipsen Biopharmaceuticals Inc.

A propos d'Ipsen:
Ipsen est un groupe biopharmaceutique mondial de taille moyenne, spécialisé dans les médicaments transformateurs dans trois aires thérapeutiques : l'oncologie, les maladies rares et les neurosciences. Forts de près de 100 ans d'expérience en développement, avec des Hubs mondiaux aux États-Unis, en France et au Royaume-Uni, nous focalisons nos efforts là où les besoins médicaux non satisfaits sont import ants, grâce à la recherche et à l'innovation.

Nos équipes passionnées, présentes dans plus de 40 pays, se concentrent sur l'essentiel et s'efforcent chaque jour d'apporter des médicaments aux patients dans 88 pays. Nous construisons un environnement de travail qui met en avant un leadership centré sur l'humain et favorise une culture de collaboration, d'excellence et d'impact. Au sein d’Ipsen, chaque individu est encouragé à être soi-même, à grandir et à s’épanouir aux côtés du succès de l'entreprise.

Rejoignez-nous dans notre démarche vers une croissance durable, en créant un impact réel sur les patients et la société. Pour plus d'informations, visitez notre site web à l'adresse  et suivez nos dernières actualités sur Linked In et Instagram.

The U.S. Hematology Brand Lead, Navtemadlin, is the senior commercial leader accountable for shaping and executing the U.S. launch of Navtemadlin within the US Oncology franchise. This role owns the integrated U.S. brand strategy, launch roadmap, market-shaping agenda, and commercial execution across relevant customer and stakeholder segments upon launch. The Brand Lead will translate scientific and market insights into a differentiated launch strategy for an oral hematology therapy and mobilize cross-functional teams to deliver launch readiness, adoption, and sustainable growth.

Success requires deep hematology/oncology expertise and commercialization experience, proven launch leadership, ability to build and manage teams, market-shaping capability, scientific acumen, and the ability to influence senior stakeholders and deliver results through a matrixed organization.

• Brand Strategy Own and drive the U.S. brand strategy, including pre-launch planning, positioning, value narrative, and long-range plan for Navtemadlin.
• Lead the end-to-end U.S. launch strategy and integrated launch plan, translating strategic choices into clear work streams, milestones, accountabilities, and decision points.
• Ensure a single, differentiated, and scientifically credible brand narrative across customer segments, channels, and cross-functional partners.
• Lead scenario planning for key clinical, regulatory, competitive, access, and operational uncertainties, and drive timely mitigation and course correction.
• Build a lifecycle strategy that anticipates future evidence, indications, combinations, customer needs, and competitive developments.
• Develop and execute a comprehensive market-shaping strategy to build disease awareness, clarify the patient journey, strengthen diagnostic and referral pathways, and prepare the market for launch.
• Identify and prioritize the stakeholders, institutions, care settings, and treatment decision points that will most influence launch success.
• Generate actionable insights from hematologists/oncologists, patients, caregivers, advocacy organizations, payers, health systems, and other relevant stakeholders.
• Partner with Medical Affairs and Market Access to address evidence, education, access, and adoption barriers within appropriate functional and compliance boundaries.
• Define the commercial model for an oral therapy, including customer engagement, patient identification, treatment initiation, adherence, persistence,…